This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders Are Loading Up On

Chelsea Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One more stock in the biotechnology and drugs complex whose insiders are buying up shares of Is Chelsea Therapeutics (CHTP), a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. This stock is off to a weak start in 2012, with shares down by around 10%.

Chelsea Therapeutics has a market cap of $287 million and an enterprise value of $223 million. This stock trades at a high valuation, with a price-to-book of 6.19. Its estimated growth rate for this year is -5.5%, and for next year it's pegged at 24%. This is a cash-rich company, since the total cash position on its balance sheet is $57.61 million and its total debt is zero.

A beneficial owner just bought 40,000 shares, or about $192,000 worth of stock, at $4.80 per share. Back in November, the chief medical officer also bought 45,141 shares, or around $200,000 worth of stock, at $4.46 per share.

From a technical standpoint, CHTP is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock hit a recent bottom at $3.25 in October, and since then it has trended higher towards its current price of $4.60. This stock is now approaching a bullish trade setup if it can manage to clear its 200-day moving average.

If you're bullish on CHTP, I would look to be a buyer on a sustained high-volume move or close back above its 200-day moving average of $4.65 a share. Look for volume that's tracking in close to or above its three-month average action of 469,229 shares. If we get that action, I would then look to add to any long positions once CHTP takes out its 50-day moving average of $4.99 with volume.

To see more stocks with notable insider buying like Senesco Technologies (CNT), MRV Communications (MRVC) and Geoeye (GEOY), check out the Stocks With Big Insider Buying portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CHTP $0.00 0.00%
ALXA $0.34 6.30%
FGP $16.41 1.40%
NIHD $3.58 -5.50%
ZIOP $4.93 -3.30%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs